Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NG&SF (Next Generation & Sequencing Facility) is a specialized service provider and core facility within the VIB (Flanders Institute for Biotechnology) ecosystem, offering advanced genomic and transcriptomic services. The company provides a comprehensive suite of next-generation sequencing (NGS) solutions, including whole-genome sequencing, RNA-seq, and single-cell analysis, to both academic and industrial partners. By leveraging state-of-the-art platforms from Illumina, Pacific Biosciences, and Oxford Nanopore, NG&SF enables high-throughput data generation and expert bioinformatics support. The facility is recognized for its technical expertise in library preparation and its ability to handle complex biological samples for diverse research applications in life sciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NG&SF.